Document Detail


High-sensitive troponin T measurements: what do we gain and what are the challenges?
MedLine Citation:
PMID:  22267244     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cardiac troponin (cTn) I and T are structural proteins unique to the heart. Detection of cTn in peripheral blood indicates cardiomyocyte damage. As acute myocardial infarction (AMI) is the most important cause of cardiomyocyte damage, cTns have become an integral part in the diagnosis of AMI. For this indication, cTns are superior to all other biomarkers and therefore are the preferred marker for the diagnosis of AMI. However, cTn indicates and provides an estimate of cardiomyocyte damage irrespective of its cause. The major limitation of contemporary cTn assays is that they are often not elevated during the initial hours of AMI. Recent advances in assay technology have led to more sensitive and precise cTn assays that will have a profound impact on clinical practice. High-sensitive cTn (hs-cTn) assays have two differentiating features from contemporary cTn assays: (i) detection of cTn in a majority of healthy persons and (ii) precise definition of what is 'normal' (=the 99th percentile). Recent multicentre studies have shown that hs-cTn assays improve the early diagnosis of patients with suspected AMI, particularly the early rule-out. To achieve best clinical use, cTn has to be interpreted as a quantitative variable. Rising and/or falling levels differentiate acute from chronic cardiomyocyte damage. The terms 'troponin-positive' and 'troponin negative' should therefore be avoided. 'Detectable' levels will become the norm and will have to be differentiated from 'elevated' levels. The differential diagnosis of a small amount of cardiomyocyte damage and therefore minor elevations of cTn is broad and includes acute and chronic cardiac disorders. The differential diagnosis of larger amount of injury and therefore more substantial elevations of cTn is largely restricted to AMI, myocarditis, and a rare patient with tako-tsubo cardiomyopathy.
Authors:
Raphael Twerenbold; Allan Jaffe; Tobias Reichlin; Miriam Reiter; Christian Mueller
Related Documents :
11230854 - Characterization of contraction and perfusion in the lateral border zone between normal...
2469084 - Influence of iloprost on eicosanoid generation and lipid levels in experimental myocard...
518794 - Acute effect of fentanyl on haemodynamics and myocardial carbohydrate utilization and p...
21603454 - Induced hypothermia as a neuroprotectant in post-cardiac arrest.
15108964 - Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion...
22016304 - The characteristics of verapamil-sensitive idiopathic left ventricular tachycardia comb...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-19
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiology, University Hospital, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Age-related effects of exercise training on diastolic function in heart failure with reduced ejectio...
Next Document:  Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a ...